Central line associated blood stream infections are associated with increased patient morbidity, mortality, and health care costs. In 2020, the target was for CLABSI rates to improve by 50% compared to the 2015 baseline. However, during COVID-19, the national SIR for CLABSI increased an average of 24% nationally and remains 22% above pre-pandemic levels.
This webinar is designed to empower staff and assist hospitals in prioritizing and implementing their CLABSI prevention efforts through diagnostic and antimicrobial stewardship, improving patient satisfaction and quality patient outcomes and optimizing and enabling reimbursement for services provided. We will further review the link between blood culture contamination and CLABSI incidence and discuss comprehensive recommendations for defining, detecting, and mitigating HAIs and false-positive CLABSIs.
Presentation topics include:
- Describe the impact of false positive blood cultures on diagnostic safety and stewardship, antimicrobial utilization and quality outcomes
- State the impact of contaminated blood cultures on CLABSI rates, patients and hospitals
- Illustrate the limitations of standard blood culture practice and the implications on CLABSI rates
- Understand the effects of False-Positive CLABSIs on the patient, the hospital and antimicrobial stewardship
- Review evidence-based practices and the critical role of the clinician in blood culture collection
- Identify tools and methods to eliminate false positive cultures leading to CLABSIs and other untoward sequelae
Wednesday, May 15, 2024: 11:00 a.m.- noon. (PT)
Tammy Johnson, RN, BS, CPM
AVP, CLINICAL STRATEGY & CUSTOMER RELATIONS
Magnolia Medical Technologies
Tammy Johnson (RN, BS, CPM; Associate Vice President Clinical Strategy and Customer Relations, Magnolia Medical Technologies) is a healthcare executive with over 30 years in nursing, 14 as a nurse leader, whose focus has been on raising standards of care for patients, optimizing outcomes and decreasing healthcare spend by first preventing patient harm. Through presentations at APIC, AVA, INS, SCASM, ENA, AHA, AONL, various hospital associations and other organizations, in addition to an invitation to address the Presidential Advisory Council Combating Antibiotic-Resistant Bacteria in Washington, DC, Tammy has championed awareness of evidence-based, metric-driven improvement processes and programs that result in sustainable, positive outcomes for patients. Tammy holds degrees in nursing, business, and health care management.
HQI is an approved continuing education (CE) provider by the California Board of Registered Nursing and will provide CHPSO members an opportunity to earn CEs. Provider Number CEP16793 for 1.0 contact hour.
Please contact CHPSO at info@chpso.org if you have any questions.